Why you might be more at risk from getting sick from a coronavirus infection if you don’t vaccinate

A new study from the Centers for Disease Control and Prevention suggests that not vaccinating against coronaviruses could help you avoid the disease.

It’s the first study to look at this possibility.

Here’s what you need to know about the study.

What the study found The researchers, led by Dr. Andrew Weil of the University of Texas Southwestern Medical Center, analyzed data from more than 16 million Americans from 2014 to 2020.

The study included 2.7 million Americans who were tested for coronaviral infection in the U.S. between June 2015 and May 2021.

They also looked at more than 1.4 million U.K. adults who had been vaccinated, and 1.3 million U to M adults who were not.

The results showed that a high level of vaccination during the previous year reduced the risk of getting a positive test for coronivirus by 42 percent.

This protection, however, came at a cost.

“The increase in vaccination did not appear to be associated with a reduction in the risk for developing influenza during follow-up,” the researchers wrote.

It also showed that the vaccination was not associated with any increase in the number of days a person had to be in an infection-free interval to develop a new coronavivirus infection. “

This is in contrast to previous findings, in which vaccination may have reduced influenza-associated morbidity,” they added.

It also showed that the vaccination was not associated with any increase in the number of days a person had to be in an infection-free interval to develop a new coronavivirus infection.

What it doesn’t show What’s more, the researchers didn’t have data for the vaccinated versus uninfecting group.

In other words, the authors didn’t know how many days they were in an infectious interval to begin a new illness or how many times the vaccinated individuals had been exposed to influenza.

The researchers then ran another analysis on a smaller subset of people, looking at people who had vaccinated but not yet had a new case of coronavire, or who had not been vaccinated at all.

This group of people showed a statistically significant decrease in the likelihood of developing a new infection.

The authors concluded that “vaccine protection may have been only slightly protective, although this is unlikely to be the case because of the small number of cases vaccinated and the large number of people who are not vaccinated.”

What this means for the U,M., &m, population Why is this important?

In addition to potentially preventing the spread of coronovirus, vaccination can help protect the U of M population from a variety of other diseases, including pneumonia, bronchitis, and influenza.

While the CDC says that there is a “possibility” that people with a weakened immune system or immune systems in general are more likely to develop complications from coronavovirus infection, this has not been demonstrated in the scientific literature.

Also, some people may be better protected from infection if they have been vaccinated.

However, the vaccine-induced protection against coroniviruses appears to be minimal in the United States, and researchers do not yet know why this is the case.

If you have questions about the importance of vaccination, or how you can protect yourself and your family, contact your doctor.

What you should know about vaccine coverage The Centers for Diseases Control and Disease Control recommends that people get the full recommended schedule of vaccinations, including two doses of two different vaccines.

The full vaccine schedule can include all seven of the vaccines included in the vaccine, plus a third vaccine that can help prevent some cancers and other diseases.

However to be effective, the vaccines must be administered at the same time.

Vaccine coverage estimates are based on the vaccine that is used in the study, not on how much of the vaccine was administered.

The CDC estimates that the full vaccine will cover 95 percent of Americans over the age of 19.

The two-dose schedule is for people 18 to 59 years old.

The three-dose vaccine is recommended for people 60 and older.